Drugs / HEKT cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03193567 | Sep 2017 → May 2025 overdue | non-small cell lung carcinoma | Ruijin Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HEKT cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03193567 ↗ |
| Modality | Cell therapy | “High Efficient Killing Cell Therapy” NCT03193567 ↗ |
| Route | Other | “HEKT cell injection” NCT03193567 ↗ |